Antibiotic resistance in tuberculosis: A growing challenge

Abstract

Tuberculosis is a disease that, despite the passage of time, continues to pose a significant threat to public health, exacerbated by the growing problem of antibiotic resistance. Caused by the bacterium Mycobacterium tuberculosis, this microorganism has developed mechanisms that make it resistant to key drugs such as rifampin and isoniazid, the cornerstone of treatment. This phenomenon, known as antimicrobial resistance, has various causes: treatment interruption, improper use of medications, and lack of access to appropriate therapies. Resistance turns the standard six-month treatment into a more complex challenge, with limited, more expensive options and higher rates of treatment failure and mortality. To address this crisis, it is essential to strengthen access to proper diagnosis and treatment, strictly follow medical regimens, and avoid self medication. Antibiotic resistance in M. tuberculosis is not only a medical obstacle but also an urgent call for collective action to protect our health and that of future generations. Let’s learn more about this ongoing global health challenge.